| 000 | 01064 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513204156.0 | ||
| 264 | 0 | _c20000428 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.46.4.450 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoo, E | |
| 245 | 0 | 0 |
_aCombination therapy of hepatitis B. _h[electronic resource] |
| 260 |
_bGut _cApr 2000 |
||
| 300 |
_a450-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLamivudine _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 700 | 1 | _aHoofnagle, J H | |
| 773 | 0 |
_tGut _gvol. 46 _gno. 4 _gp. 450-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.46.4.450 _zAvailable from publisher's website |
| 999 |
_c10670571 _d10670571 |
||